The Patent Finder

Legochem Biosciences, Inc.

Also on record
Records under this name other than the patents Legochem Biosciences, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 24 patents it holds.

Showing 1 to 7 of 7 · Back to Legochem Biosciences, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,637,667Method for preparing (S)-5-chloro-N-((3-(4-(5,6-dihydro-4H-1,2,4-oxadiazin-3-yl)phenyl)-2-oxooxazolidin-5-yl)methyl)thiophene-2-carboxamide derivatives
Lapsed on the fee record
Ended Jan 28, 2026 · USPTO record
Lapsed on the fee recordEnded Jan 28, 2026USPTO record
US 8,288,423FXa inhibitors with cyclic amidines as P4 subunit, processes for their preparations, and pharmaceutical compositions and derivatives thereof
Lapsed on the fee record
Ended Oct 16, 2024 · USPTO record
Lapsed on the fee recordEnded Oct 16, 2024USPTO record
US 10,273,235Compositions and methods for inhibiting β-lactamase
Lapsed on the fee record
Ended Apr 30, 2023 · USPTO record
Lapsed on the fee recordEnded Apr 30, 2023USPTO record
US 8,846,669Oxazolidinone derivative and medical composition containing same
Lapsed on the fee record
Ended Sep 30, 2022 · USPTO record
Lapsed on the fee recordEnded Sep 30, 2022USPTO record
US 9,951,072Compositions and methods for inhibiting beta-lactamase
Lapsed on the fee record
Ended Apr 24, 2022 · USPTO record
Lapsed on the fee recordEnded Apr 24, 2022USPTO record
US 9,630,977Cephalosporin derivatives and pharmaceutical compositions thereof
Lapsed on the fee record
Ended Apr 25, 2021 · USPTO record
Lapsed on the fee recordEnded Apr 25, 2021USPTO record
US 8,329,684Cephalosporin derivatives and pharmaceutical compositions thereof
Lapsed on the fee record
Ended Dec 11, 2020 · USPTO record
Lapsed on the fee recordEnded Dec 11, 2020USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited